Oncopharmpod
API-CAT & IMPROVE
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:42
- Mas informaciones
Informações:
Sinopsis
We discuss reduced dose apixaban for months 6+ of treating cancer-associated VTE (API-CAT) and the impact (or lack thereof) of pausing BTK-inhibitors around vaccination (IMPROVE)
